GlobeNewsWire
24 Jul 2026, 19:41 UTC · 1h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
2 claims · each scored for market impact
A class action lawsuit has been filed against ADMA Biologics, Inc. for securities purchased between August 9, 2024, and March 25, 2026. — Class action lawsuits create legal uncertainty and potential financial liabilities, which typically weigh on a company's stock price.
-0.40The deadline to file a lead plaintiff motion for the ADMA Biologics class action is August 10, 2026. — This is a procedural deadline that signals the progression of the legal process but does not change the fundamental risk profile.
-0.10Which stocks this story touches
The company is the subject of a class action lawsuit involving investors.
Continue reading
6 related stories
Search tags
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
Newsfile Corp
55m ago
